LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Liposomal bupivacaine in minimally invasive thoracic surgery: something is rotten in the state of Denmark.

Photo by elnazasadi from unsplash

In the last decade, incorporation of minimally invasive approaches for a vast array of thoracic procedures has improved perioperative patient outcomes, however adequate postoperative pain control for thoracic patients remains… Click to show full abstract

In the last decade, incorporation of minimally invasive approaches for a vast array of thoracic procedures has improved perioperative patient outcomes, however adequate postoperative pain control for thoracic patients remains a challenge. Inadequate pain control may result in adverse sequelae such as hypoventilation, retained secretions, respiratory failure, decreased mobility, and prolonged hospital stay (1). There is ample evidence in the literature of the effect these adverse events can have on postoperative morbidity and mortality.

Keywords: liposomal bupivacaine; minimally invasive; thoracic; invasive thoracic; thoracic surgery; bupivacaine minimally

Journal Title: Journal of thoracic disease
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.